Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Cantex Pharmaceuticals, Inc. | 10%+ Owner | $3.34M | Sep 14, 2021 | ||
Michael T. Andriole | PRESIDENT AND CEO, Director | $2.53M | -$12.5K | -0.49% | Jan 30, 2025 |
Michelle LaSpaluto | Chief Financial Officer | $720K | -$6.19K | -0.85% | Jan 30, 2025 |
Fred A. Middleton | Director | $695K | Oct 28, 2024 | ||
David Jakeman | Vp Of Finance And Accounting | $612K | -$14.2K | -2.28% | Jan 30, 2025 |
Michael Alrutz | Svp And General Counsel | $178K | Jan 7, 2025 | ||
Allen S. Melemed | Chief Medical Officer | $129K | Jan 7, 2025 | ||
Thomas J. Riga | COO and CCO | $47.6K | Jan 7, 2025 | ||
Robert J. Meyer | Director | Jun 20, 2024 | |||
Michael A. Sherman | Chief Executive Officer, Director | Jun 20, 2024 | |||
Marc D. Kozin | Director | Jun 20, 2024 | |||
Martha J. Demski | Director | Jun 20, 2024 | |||
Pratik S. Multani | Director | Jun 20, 2024 | |||
Lisa Lynn Decker | Director | Jun 20, 2024 | |||
Catherine Gilliss | Director | Jun 9, 2023 | |||
Victoria Vakiener | Director | Jun 20, 2024 | |||
Patrick Machado | Director | Jun 9, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|